BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29859866)

  • 1. Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center.
    Hanfelt JJ; Peng L; Goldstein FC; Lah JJ
    Neurobiol Dis; 2018 Sep; 117():62-71. PubMed ID: 29859866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective predictors of decline
    Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; McKeith IG; Thomas AJ
    Psychol Med; 2021 Nov; 51(15):2590-2598. PubMed ID: 32366348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal lifestyle engagement patterns support cognitive stability beyond neuropathological burden.
    Paolillo EW; Saloner R; VandeBunte A; Lee S; Bennett DA; Casaletto KB
    Alzheimers Res Ther; 2023 Dec; 15(1):221. PubMed ID: 38111051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer's Coordinating Center.
    Hanfelt JJ; Wuu J; Sollinger AB; Greenaway MC; Lah JJ; Levey AI; Goldstein FC
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):940-50. PubMed ID: 22024618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.
    Leoutsakos JM; Forrester SN; Lyketsos CG; Smith GS
    J Alzheimers Dis; 2015; 48(2):483-93. PubMed ID: 26402012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropathology of mild cognitive impairment].
    Takao M
    Rinsho Shinkeigaku; 2012; 52(11):851-4. PubMed ID: 23196441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis.
    Roberto N; Portella MJ; Marquié M; Alegret M; Hernández I; Mauleón A; Rosende-Roca M; Abdelnour C; de Antonio EE; Gil S; Tartari JP; Vargas L; Espinosa A; Ortega G; Pérez-Cordón A; Sanabria Á; Orellana A; de Rojas I; Moreno-Grau S; Montrreal L; Alarcón-Martín E; Ruíz A; Tárraga L; Boada M; Valero S
    Sci Rep; 2021 Mar; 11(1):6448. PubMed ID: 33742011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk classification for conversion from mild cognitive impairment to Alzheimer's disease in primary care.
    Qin Y; Tian Y; Han H; Liu L; Ge X; Xue H; Wang T; Zhou L; Liang R; Yu H;
    Psychiatry Res; 2019 Aug; 278():19-26. PubMed ID: 31132572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
    Kondo D; Ota K; Kasanuki K; Fujishiro H; Chiba Y; Murayama N; Sato K; Hirayasu Y; Arai H; Iseki E
    J Neurol Sci; 2016 Oct; 369():102-108. PubMed ID: 27653873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
    Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
    Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early differentiation of dementia with Lewy bodies and Alzheimer's disease: Heart rate variability at mild cognitive impairment stage.
    Kim MS; Yoon JH; Hong JM
    Clin Neurophysiol; 2018 Aug; 129(8):1570-1578. PubMed ID: 29883835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer's neuropathology.
    Teylan M; Besser LM; Crary JF; Mock C; Gauthreaux K; Thomas NM; Chen YC; Kukull WA
    Lab Invest; 2019 Jul; 99(7):1049-1055. PubMed ID: 30710118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis.
    Eppig JS; Edmonds EC; Campbell L; Sanderson-Cimino M; Delano-Wood L; Bondi MW;
    J Int Neuropsychol Soc; 2017 Aug; 23(7):564-576. PubMed ID: 28578726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after diagnosis of mild cognitive impairment in a large autopsy series.
    Abner EL; Kryscio RJ; Schmitt FA; Fardo DW; Moga DC; Ighodaro ET; Jicha GA; Yu L; Dodge HH; Xiong C; Woltjer RL; Schneider JA; Cairns NJ; Bennett DA; Nelson PT
    Ann Neurol; 2017 Apr; 81(4):549-559. PubMed ID: 28224671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.